Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Terminated
3(33%)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_2
2
22%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(4)
Terminated(3)
Other(2)

Detailed Status

Completed4
Terminated3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
57.1%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (22.2%)
N/A7 (77.8%)

Trials by Status

terminated333%
completed444%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9